Skip to main content
. 2021 Feb 15;11:3843. doi: 10.1038/s41598-021-83217-w

Table 3.

Geometric means of plasma concentration of fibrinogen by quintiles of micronutrient intake in the ENRICA study (N = 10,808).

Micronutrient intake P for trend
Q 1 (lowest. Reference) (n = 2161)
Mean (g/L) (95% CI)
Q 2 (n = 2162)
Mean (g/L) (95% CI)
Q 3 (n = 2162)
Mean (g/L) (95% CI)
Q 4 (n = 2162)
Mean (g/L) (95% CI)
Q 5 (n = 2161)
Mean (g/L) (95% CI)
Carotenoids
Range (µg/d) < 1573 1573–2261 2261–2994 2994–4136 > 4136
Model 1a 3.26 (3.22; 3.29) 3.26 (3.17; 3.34) 3.20 (3.12; 3.29)* 3.22 (3.13; 3.30) 3.20 (3.12; 3.29)* 0.011
Model 2b 3.22 (3.15; 3.29) 3.23 (3.12; 3.35) 3.19 (3.07; 3.31) 3.20 (3.09; 3.32) 3.20 (3.08; 3.31) 0.222
Model 3c 3.19 (3.10; 3.28) 3.21 (3.07; 3.35) 3.17 (3.03; 3.32) 3.19 (3.05; 3.34) 3.20 (3.05; 3.35) 0.911
Vitamin B6
Range (mg/d) < 1.6 1.6–1.8 1.8–2.0 2.0–2.4 > 2.4
Model 1 3.26 (3.22; 3.30) 3.24 (3.16; 3.32) 3.22 (3.15; 3.31) 3.20 (3.12; 3.28)** 3.22 (3.14; 3.30) 0.043
Model 2 3.23 (3.16; 3.30) 3.21 (3.10; 3.33) 3.21 (3.10; 3.33) 3.18 (3.07; 3.30)** 3.21 (3.09; 3.33) 0.271
Model 3 3.19 (3.10; 3.28) 3.19 (3.05; 3.33) 3.20 (3.07; 3.35) 3.20 (3.05; 3.34) 3.24 (3.08; 3.40) 0.139
Vitamin C
Range (mg/d) < 64.0 64.0–90.6 90.6–118.1 118.1–161.0 > 161.0
Model 1 3.28 (3.24; 3.32) 3.21 (3.13; 3.29)** 3.25 (3.17; 3.33) 3.18 (3.10; 3.26)*** 3.22 (3.14; 3.30)** 0.004
Model 2 3.23 (3.16; 3.30) 3.19 (3.08; 3.31) 3.23 (3.12; 3.35) 3.17 (3.06; 3.29)* 3.22 (3.10; 3.33) 0.519
Model 3 3.19 (3.10; 3.28) 3.15 (3.02; 3.30) 3.20 (3.06; 3.34) 3.15 (3.01; 3.29) 3.19 (3.05; 3.35) 0.786
Vitamin E
Range (mg/d) < 7.0 7.0–8.8 8.8–10.4 10.4–12.9 > 12.9
Model 1 3.25 (3.22; 3.29) 3.25 (3.17; 3.34) 3.24 (3.16; 3.32) 3.18 (3.10; 3.26)** 3.20 (3.12; 3.28)* 0.001
Model 2 3.22 (3.15; 3.30) 3.22 (3.11; 3.35) 3.22 (3.10; 3.34) 3.16 (3.05; 3.28)** 3.19 (3.07; 3.31) 0.030
Model 3 3.19 (3.10; 3.28) 3.20 (3.07; 3.35) 3.20 (3.06; 3.35) 3.16 (3.02; 3.31) 3.18 (3.03; 3.34) 0.524
Magnesium
Range (mg/d) < 266.2 266.2–295.0 295.0–324.6 324.6–368.4 > 368.4
Model 1 3.27 (3.23; 3.31) 3.25 (3.17; 3.33) 3.22 (3.14; 3.30)* 3.20 (3.12; 3.29)** 3.19 (3.11; 3.28)** 0.001
Model 2 3.23 (3.16; 3.31) 3.22 (3.10; 3.33) 3.20 (3.09; 3.31) 3.19 (3.07; 3.30)* 3.19 (3.07; 3.31) 0.047
Model 3 3.19 (3.10; 3.28) 3.18 (3.04; 3.32) 3.17 (3.03; 3.32) 3.16 (3.02; 3.31) 3.17 (3.02; 3.33) 0.571
Iron
Range (mg/d)  < 11.5 11.5–12.7 12.7–13.7 13.7–15.3 > 15.3
Model 1 3.27 (3.23; 3.31) 3.24 (3.16; 3.32) 3.21 (3.13; 3.30)* 3.23 (3.14; 3.31) 3.19 (3.11; 3.28)** 0.003
Model 2 3.24 (3.16; 3.31) 3.22 (3.10; 3.34) 3.19 (3.08; 3.31) 3.21 (3.09; 3.33) 3.19 (3.07; 3.31) 0.050
Model 3 3.19 (3.10; 3.28) 3.17 (3.04; 3.31) 3.15 (3.01; 3.29) 3.16 (3.02; 3.31) 3.14 (2.99; 3.29) 0.114

*p ≤ 0.05 **p < 0.01 ***p < 0.001. P values for differences in plasma fibrinogen levels across quintiles of micronutrients intake (quintile 1 as reference) using the above linear regression models.

aModel 1: linear regression model adjusted for age and sex.

bModel 2: adjusted as model 1 and for educational level (≤ Primary, Secondary, University), smoking status (never smoker, former smoker, current smoker), heavy drinking (yes, no), leisure-time physical activity (quintiles of METs-h/w), energy intake (quintiles of kcal/d), Body Mass Index ≥ 30 (yes, no), chronic lung disease, cardiovascular disease, cancer, depression, hypercholesterolemia, diabetes, hypertension and rheumatoid arthritis (yes, no).

cModel 3: adjusted as model 2 and for fibre (quintiles of intake), carbohydrates (quintiles of intake), unsaturated fats (quintiles of intake), sodium (quintiles of intake) and all other micronutrients in the table (quintiles of intake).